MedTrace Logo

Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)

NCT06531681 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-02-13

No results posted yet for this study

Summary

Aim to observe the application of MR-Linac for precision radiotherapy of tumours, analyse its therapeutic effect, toxic and side effects,Characteristics of dosimetric parameters etc.

Conditions

  • Overall Response Rate
  • Oncology
  • Radiation Toxicity
  • Quality of Life

Interventions

DEVICE

MR-Linac

Radiation therapy with the MR-Linac

Sponsors & Collaborators

  • The Second Affiliated Hospital of Hainan Medical University

    lead OTHER

Principal Investigators

  • yuecan zeng, doctor · The Second Affiliated Hospital of Hainan Medical University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-19
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06531681 on ClinicalTrials.gov